About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Maryland | 900 Studies

Clinical Trials Breast CancerMaryland

Breast Cancer Clinical Trials in Maryland

Find 900 clinical trials for breast cancer near Maryland. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 421-440 of 900 trials

CompletedEvaluating Patient Information PrescriptionsResearch shows that patient satisfaction with medical care correlates strongly with how satisfied they are with the ease of getting information from their providers regarding…NCT00355381·Baltimore, Maryland TerminatedA Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast CancerThis research study is designed to look at the effects of the combination of vorinostat (Suberoylanilide Hydroxamic Acid or Zolinza) and tamoxifen on breast cancer tissue.NCT01194427·Baltimore, Maryland Active not recruitingDigital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast CancerThis randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer.NCT03233191·Birmingham, Alabama and 148 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedComplementary or Alternative Medicine Practices Used by Women at Increased Risk for Breast CancerRATIONALE: Increasing knowledge about the complementary or alternative medicine practices used by women who are at increased risk for breast cancer may provide useful information…NCT00020098·Bethesda, Maryland and 1 other

CompletedEvaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationThis is an open label, randomized, multicenter study evaluating the activity of lasofoxifene relative to fulvestrant for the treatment of pre- and postmenopausal women with…NCT03781063·Phoenix, Arizona and 50 others

CompletedIntravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal CarcinomatosisBackground: Tumors that have spread to the lining of the abdomen from other cancers, such as cancer of the appendix, colon, or ovary, are called peritoneal carcinomatosis.NCT05185947·Bethesda, Maryland

Active not recruitingStudy of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsThis is an open-label, multicenter Phase 1 study to evaluate safety, tolerability and preliminary efficacy of oral LY3410738 in patients with isocitrate dehydrogenase 1 (IDH1)…NCT04521686·Phoenix, Arizona and 32 others

CompletedAdjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast CancerThis was an open label, multi-center protocol for U.S. patients enrolled in the study of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone…NCT03078751·Tucson, Arizona and 32 others

CompletedA Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast CancerThis randomized, open-label, two-arm, multi-center, Phase II study will evaluate the efficacy and safety of pertuzumab in combination with trastuzumab plus an aromatase inhibitor…NCT01491737·Birmingham, Alabama and 81 others

TerminatedStudy of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)This randomized phase 3 trial is studying the effect of denosumab to see if it can prevent disease recurrence in the bone or in any other part of the body, when it is given as…NCT01077154·Birmingham, Alabama and 458 others

CompletedPRospective Study Of MammaPrint in Patients With an Intermediate Recurrence ScoreThis is a prospective study that will assess the impact of MammaPrint on chemotherapy + endocrine versus endocrine alone treatment decisions in patients with an Oncotype…NCT01617954·Phoenix, Arizona and 52 others

CompletedProspective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer PatientsThis multicenter, prospectively designed study examines whether the Prosigna score influences physician and patient adjuvant treatment selection over and above currently used…NCT02625935·Fort Myers, Florida and 3 others

CompletedTrilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of trilaciclib versus placebo administered prior to…NCT04799249·Gilbert, Arizona and 70 others

TerminatedStudy to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsThe purpose of this study is to test the combination of an experimental drug known as MGCD0103 given along with an FDA-approved drug called docetaxel.NCT00511576·Baltimore, Maryland and 1 other

CompletedS0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone ThpyRATIONALE: An omega-3 fatty acid-enriched nutritional supplement may help improve muscle and bone pain and stiffness caused by hormone therapy in patients with breast cancer.NCT01385137·Mobile, Alabama and 291 others

TerminatedRandomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast CancerThe purpose of this study is to assess the effect of ixabepilone plus capecitabine or docetaxel plus capecitabine on shrinking or slowing the growth of metastatic breast cancer in…NCT00546364·Tuscaloosa, Alabama and 59 others

TerminatedRibociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic SubtypeHARMONIA is an international, multicenter, randomized, open-label and phase III study.NCT05207709·Clearwater, Florida and 70 others

CompletedEvaluation of the Cook Biodesign® Nipple Reconstruction Cylinder (NRC)Patients with a desire for nipple reconstruction following breast cancer and breast reconstruction will receive a surgical procedure to reconstruct one or both nipples utilizing…NCT01216319·Stanford, California and 3 others

Active not recruitingCarboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast CancerRATIONALE: Drugs used in chemotherapy, such as carboplatin and paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells…NCT00616967·Birmingham, Alabama and 4 others

Enrolling by invitationAdvanced Ultrasound Signal Processing of Suspicious Breast ImagesThis study aims to investigate recent developments in ultrasound signal processing to determine if these new techniques can enhance the visibility of important features of…NCT07206888·Baltimore, Maryland

PreviousPage 22 of 45Next

Other Conditions in Maryland

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma